Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma.
Mizumura K, Gon Y, Harada N, Yamada S, Fukuda A, Ozoe R, Maruoka S, Abe S, Takahashi K, Tanaka A, Sagara H, Akamatsu T, Shirai T, Masaki K, Fukunaga K, Kobayashi K, Nagase H, Miyahara N, Kanehiro A, Kitamura N, Sugihara N, Kumasawa F, Terada-Hirashima J, Hojo M, Chibana K, Tagaya E.
Mizumura K, et al. Among authors: sugihara n.
Allergol Int. 2025 Jan;74(1):144-155. doi: 10.1016/j.alit.2024.08.005. Epub 2024 Sep 13.
Allergol Int. 2025.
PMID: 39277433
Free article.